A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis

Archives of Disease in Childhood

Volumn 90, Issue 4, 2005, Pages 391-396

  McIntyre, P B ^a   MacIntyre, C R ^a   Gilmour, R ^a   Wang, H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; PENICILLIN G;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; CORTICOSTEROID THERAPY; DRUG USE; EARLY DIAGNOSIS; FEMALE; HEALTH CARE ACCESS; HUMAN; INFANT; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; NEUROLOGIC DISEASE; NEWBORN; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; NEW SOUTH WALES; ODDS RATIO; PENICILLIN RESISTANCE; REGISTRIES; SPINAL PUNCTURE; TIME FACTORS; TREATMENT OUTCOME;

EID: 16844386790     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.037523     Document Type: Article

References (27)

1. Short WR, Tunkel AR. Changing epidemiology of bacterial meningitis in the United States. Current Infectious Disease Reports 2000;2:327-31.
2. McIntyre P, Gidding HF, Gilmour R, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Comm Dis Intell 2002;(suppl May).
3. Grimwood K, Nolan TM, Band L, et al. Risk factors for adverse outcomes of bacterial meningitis. J Paediatr Child Health 1996;32:457-62.
4. Neuman HB, Wald ER. Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998. Clin Pediatr 2001;40:595-600.
5. Kaplan SL. Management of pneumococcal meningitis. Pediatr Infect Dis J 2002;21:589-91.
6. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992;11:694-701.
7. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
8. McMaster P, McIntyre P, Gilmour R, et al. The emergence of resistant pneumococcal meningitis-implications for empiric therapy. Arch Dis Child 2002;87:207-11.
9. National Coding Centre. ICD-P-CM, The official NCC Australian version. Sydney: Faculty of Health Sciences, University of Sydney, 1995.
10. Liddle JL, McIntyre PB, Davis CW. Incidence of invasive pneumococcal disease in Sydney children, 1991-96. J Paediatr Child Health 1999;35:67-70.
11. The Australian immunisation handbook, 8th edn. Canberra: Australian Government Publishing Service, 2003.
12. Dean AG, Dean JA, Coulombier D, et al. Epi Info 6. Atlanta, GA: Centers for Disease Control, 1999.
13. Statistics and Epidemiology Research Corporation. EGRET for Windows. Seattle, WA: Cytel Software Corporation, 1999.
14. Grimwood K, Anderson P, Anderson V, et al. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000;83:111-16.
15. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988;319:964-71.
16. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
17. Schaad UB, Lips U, Gnehm HE, et al. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 1993;342:457-61.
18. Kanra GY, Ozen H, Secmeer G, et al. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995;14:490-4.
19. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-18.
20. Kellner JD, Scheifele DW, Halperin SA, et al. Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J 2002;21:903-10.
21. de Gans J, van de Beek D. European Dexamethasone in Adulthood Bacterial Meningitis Study I. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-56.
22. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
23. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-97.
24. Buckingham SC, McCullers JA, Lujan-Zilbermann J, et al. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 2001;20:837-43.
25. Kallio MJ, Kilpi T, Anttila M, et al. The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA 1994;272:787-91.
26. Kilpi T, Anttila M, Kallio MJ, et al. Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Pediatr Infect Dis J 1993;12:184-8.
27. Kilpi T, Anttila M, Kallio MJ, et al. Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet 1991;338:406-9.